ACTRN12612001198819招募中未知
A study to assess insulin signal peptide (INSsp) as a measure of pancreatic beta islet cell function and mass through clinical studies of blood samples from donors including thoose who are healthy, pre-diabetic and with Type 1 and Type 2 diabetes mellitus
Ministry of Business, Innovation & Employment0 个研究点目标入组 320 人开始时间: 2012年11月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20 Years 至 70 Years（—）
- 性别
- All
入选标准
- •5 groups of participants will be invited to take part in this study:
- •1. 100 normal, healthy volunteers (50 men, 50 woman) aged between 20-70
- •2. 70 female patients referred for glucose load testing in the first trimester of pregnancy.
- •3. 50 patients with polycystic ovary syndrome (PCOS)
- •4. 50 patients identified from the population as at risk of having Type 2 Diabetes Mellitus (pre-diabetes)
- •5. 50 patients each with diagnosed Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus
排除标准
- •unwilling or unable to give informed consent
研究者
相似试验
进行中（未招募）
不适用
Estudio de superioridad de insulina glargina frente a sitagliptina en pacientes con diabetes tipo 2, sin experiencia previa de insulinoterapia, que reciben tratamiento con metformina y no están suficientemente controlados - EASIEDiabetes tipo 2 tratado con metformina y no suficientemente controladaMedDRA version: 9.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlEUCTR2008-000516-32-ESsanofi aventis Groupe530
尚未招募
不适用
A pilot study of association between insulin resistance markers in T2DM patients with or without coronary artery diseaseCoronary Artery DiseaseT2DM patients with Coronary Artery DiseaseType 2 Diabetes MellitusTriglyceride Glucose index (TyG)Homeostatic Model Assessment Insulin Resistance (HOMA-IR)Insulin ResistanceTCTR20220804006Theptarin Hospital50
进行中（未招募）
不适用
Clinical study on the insulin sensitizing effect of multiple administration of Vition (Meditop) in healthy human volunteers (Pilot study)EUCTR2011-001859-36-HUMeditop Pharmaceuticals Co. Ltd.
进行中（未招募）
3 期
A 26-week trial comparing the effect and safety of once weekly insulin icodec and once daily insulin glargine 100 units/mL, both in combination with bolus insulin with or without non-insulin anti-diabetic drugs, in subjects with type 2 diabetes on a basal-bolus regimen. ONWARDS 4.CTRI/2021/06/034231ovo Nordisk Denmark
已完成
不适用
Study on measurement external injected insulihealthy volunteerJPRN-UMIN000002279Kobe University Graduate School of medicine8